Protalix BioTherapeutics
PLX
#8578
Rank
NZ$0.20 B
Marketcap
$2.84
Share price
-1.78%
Change (1 day)
22.02%
Change (1 year)

Protalix BioTherapeutics (PLX) - Cash on Hand

Cash on Hand as of June 2024 : NZ$77.08 Million

According to Protalix BioTherapeutics 's latest financial reports the company has NZ$77.08 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Protalix BioTherapeutics - Cash on Hand chart (from 1999 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$70.46 M101.7%
2022-12-31NZ$34.93 M-38.79%
2021-12-31NZ$57.07 M6.84%
2020-12-31NZ$53.42 M102.21%
2019-12-31NZ$26.41 M-53.13%
2018-12-31NZ$56.36 M-21.76%
2017-12-31NZ$72.04 M-21.14%
2016-12-31NZ$91.35 M-18.13%
2015-12-31NZ$0.11 B59.64%
2014-12-31NZ$69.89 M-33.52%
2013-12-31NZ$0.10 B66.22%
2012-12-31NZ$63.25 M82.83%
2011-12-31NZ$34.59 M-25.65%
2010-12-31NZ$46.53 M-58.41%
2009-12-31NZ$0.11 B52.43%
2008-12-31NZ$73.4 M-9.04%
2007-12-31NZ$80.69 M147.66%
2006-12-31NZ$32.58 M369.75%
2005-12-31NZ$6.93 M777.56%
2004-12-31NZ$0.79 M-29.79%
2003-12-31NZ$1.12 M-27.05%
2002-12-31NZ$1.54 M-30.01%
2001-12-31NZ$2.2 M-39.23%
2000-12-31NZ$3.62 M29.07%
1999-12-31NZ$2.81 M14.9%
1998-12-31NZ$2.44 M159.13%
1997-12-31NZ$0.94 M-12.68%
1996-12-31NZ$1.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.42 B 454.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.10 B 2,627.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.03 B 22,001.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.68 B 7,270.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel